Specifically, they proposed an approach in which GLP-1RAs could be prescribed for an initial period of weight loss before patients transitioned to cheaper alternative interventions for weight maintenance such as lower-cost medications, behavioral health programs and support from nutritionists
Table 6: Results at Week 52 in a Trial Comparing TRESIBA to Insulin Glargine U-100 (Study A) and Week 26 in a Trial Comparing TRESIBA to Insulin Detemir (Study B) in Adult Patients with Type 1 Diabetes Mellitus Receiving Insulin Aspart at Mealtimes Study C TRESIBA Administered at the Same Time Each Day or at Any Time Each Day in Combination with a Rapid Acting Insulin Analog at Mealtimes in Adult Patients The efficacy of TRESIBA was evaluated in a 26 week randomized, open label, multicenter trial in 493 patients with type 1 diabetes mellitus
This guide gives patients an understanding of Farxigas effectiveness for weight loss
Some in-person weight management clinics also prescribe compounded semaglutide
Significant weight loss from GLP-1 therapy may reduce levothyroxine requirements in some patients
however, experts advise that it should be used in pregnancy only if the potential benefit clearly outweighs any potential risk